Correlation Between Gemini Group and Cyclacel Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gemini Group and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gemini Group and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gemini Group Global and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Gemini Group and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gemini Group with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gemini Group and Cyclacel Pharmaceuticals.

Diversification Opportunities for Gemini Group and Cyclacel Pharmaceuticals

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Gemini and Cyclacel is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Gemini Group Global and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Gemini Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gemini Group Global are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Gemini Group i.e., Gemini Group and Cyclacel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Gemini Group and Cyclacel Pharmaceuticals

If you would invest  0.35  in Gemini Group Global on August 31, 2024 and sell it today you would earn a total of  0.00  from holding Gemini Group Global or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Gemini Group Global  vs.  Cyclacel Pharmaceuticals

 Performance 
       Timeline  
Gemini Group Global 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gemini Group Global has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Gemini Group is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
Cyclacel Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyclacel Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest inconsistent performance, the Preferred Stock's fundamental indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Gemini Group and Cyclacel Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gemini Group and Cyclacel Pharmaceuticals

The main advantage of trading using opposite Gemini Group and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gemini Group position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.
The idea behind Gemini Group Global and Cyclacel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device